Article
BioPathfinder: Evidence-guided multi-agent platform enables hypothesis discovery for CAR-T engineering
2026-07-16
Abstract excerpt
<h4>ABSTRACT</h4> Clinical studies of chimeric antigen receptor (CAR)-T therapy generate diverse molecular and clinical evidence that remains fragmented across publications, public repositories and patient-derived datasets, limiting systematic therapeutic discovery. Here we present BioPathfinder, an evidence-guided multi-agent workflow for closed-loop biomedical discovery. BioPathfinder constructs a provenance-aw...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 830e50ed-506e-5c25-86cc-bd07c367894b
- DOI
- 10.64898/2026.07.15.738646
